These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34957292)

  • 21. Microbial etiology and antibiotic resistance in urinary tract infections in children; view from an area where antibiotics are overused.
    Samanci S; Pınarbaşı AS
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7680-7687. PubMed ID: 37667945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of hospital-acquired uropathogens to first-line antimicrobial agents at a tertiary health-care hospital, Saudi Arabia.
    Alamri A; Hassan B; Hamid ME
    Urol Ann; 2021; 13(2):166-170. PubMed ID: 34194144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance to oral antibiotics in 4569 Gram-negative rods isolated from urinary tract infection in children.
    Calzi A; Grignolo S; Caviglia I; Calevo MG; Losurdo G; Piaggio G; Bandettini R; Castagnola E
    Eur J Pediatr; 2016 Sep; 175(9):1219-1225. PubMed ID: 27558493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria.
    Keating GM
    Drugs; 2013 Nov; 73(17):1951-66. PubMed ID: 24202878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fosfomycin Susceptibility in Multidrug-Resistant Enterobacteriaceae Species and Vancomycin-Resistant Enterococci Urinary Isolates.
    Ou LB; Nadeau L
    Can J Hosp Pharm; 2017; 70(5):368-374. PubMed ID: 29109580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant
    Amladi AU; Abirami B; Devi SM; Sudarsanam TD; Kandasamy S; Kekre N; Veeraraghavan B; Sahni RD
    Indian J Med Res; 2019 Feb; 149(2):185-191. PubMed ID: 31219082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility and emerging resistance determinants (blaCTX-M, rmtB, fosA3) in clinical isolates from urinary tract infections in the Bolivian Chaco.
    Bartoloni A; Sennati S; Di Maggio T; Mantella A; Riccobono E; Strohmeyer M; Revollo C; Villagran AL; Pallecchi L; Rossolini GM
    Int J Infect Dis; 2016 Feb; 43():1-6. PubMed ID: 26686940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral treatment options for patients with urinary tract infections caused by extended spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae.
    Raja NS
    J Infect Public Health; 2019; 12(6):843-846. PubMed ID: 31176606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Etiology of Community-Acquired and Nosocomial Urinary Tract Infections and Antibiotic Resistance of Isolated Strains: Results of a 3-Year Surveillance (2020-2022) at the Pediatric Teaching Hospital in Warsaw.
    Wanke-Rytt M; Sobierajski T; Lachowicz D; Seliga-Gąsior D; Podsiadły E
    Microorganisms; 2023 May; 11(6):. PubMed ID: 37374940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etiology and Antimicrobial Susceptibility of Pathogens Associated with Urinary Tract Infections among Women Attending Antenatal Care in Four South African Tertiary-Level Facilities, 2015-2019.
    Zwane T; Shuping L; Perovic O
    Antibiotics (Basel); 2021 Jun; 10(6):. PubMed ID: 34199691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Uropathogen pattern and antimicrobial susceptibility in positive urinary cultures isolates from paediatric patients].
    Moya-Dionisio V; Díaz-Zabala M; Ibáñez-Fernández A; Suárez-Leiva P; Martínez-Suárez V; Ordóñez-Álvarez FA; Santos-Rodríguez F
    Rev Esp Quimioter; 2016 Jun; 29(3):146-50. PubMed ID: 27092771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidrug resistance and extended-spectrum β-lactamases genes among Escherichia coli from patients with urinary tract infections in Northwestern Libya.
    Abujnah AA; Zorgani A; Sabri MA; El-Mohammady H; Khalek RA; Ghenghesh KS
    Libyan J Med; 2015; 10(1):26412. PubMed ID: 25651907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012.
    Keepers TR; Gomez M; Celeri C; Krause KM; Biek D; Critchley I
    Infect Dis Ther; 2017 Jun; 6(2):233-243. PubMed ID: 28285420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.
    Meier S; Weber R; Zbinden R; Ruef C; Hasse B
    Infection; 2011 Aug; 39(4):333-40. PubMed ID: 21706226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, Pathogenic Bacterial Profile and Antimicrobial Susceptibility Pattern of Urinary Tract Infection Among Children with Congenital Anomalies of the Kidney and Urinary Tract.
    Zhang K; Zhang Y; Chao M; Hao Z
    Infect Drug Resist; 2023; 16():4101-4112. PubMed ID: 37396068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Susceptibility to Selected Antibiotics in
    Rostkowska OM; Kuthan R; Burban A; Salińska J; Ciebiera M; Młynarczyk G; Durlik M
    Antibiotics (Basel); 2020 May; 9(6):. PubMed ID: 32466463
    [No Abstract]   [Full Text] [Related]  

  • 37. [National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients].
    Wagenlehner FM; Schmiemann G; Hoyme U; Fünfstück R; Hummers-Pradier E; Kaase M; Kniehl E; Selbach I; Sester U; Vahlensieck W; Watermann D; Naber KG
    Urologe A; 2011 Feb; 50(2):153-69. PubMed ID: 21312083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibility of bacterial uropathogens in a South African regional hospital.
    Naidoo A; Kajee A; Mvelase NR; Swe-Han KS
    Afr J Lab Med; 2023; 12(1):1920. PubMed ID: 37063604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: a 7-year surveillance study.
    Sorlozano A; Jimenez-Pacheco A; de Dios Luna Del Castillo J; Sampedro A; Martinez-Brocal A; Miranda-Casas C; Navarro-Marí JM; Gutiérrez-Fernández J
    Am J Infect Control; 2014 Oct; 42(10):1033-8. PubMed ID: 25278389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility of Nitrofurantoin and Fosfomycin Against Outpatient Urinary Isolates of Multidrug-Resistant Enterococci over a Period of 10 Years from India.
    Das A; Banerjee T; Anupurba S
    Microb Drug Resist; 2020 Dec; 26(12):1509-1515. PubMed ID: 31794690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.